Načítá se...
Progresses in clinical studies on antiviral therapies for COVID‐19—Experience and lessons in design of clinical trials
Antiviral therapy with antiviral agents is a very important component of treatment for the 2019 novel coronavirus disease (COVID‐19) caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). It is important to clarify how to evaluate efficacy and safety of antiviral agents in treat...
Uloženo v:
| Vydáno v: | Pediatr Investig |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7768300/ https://ncbi.nlm.nih.gov/pubmed/33376954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ped4.12227 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|